SEC Form 4 · accession 0001562180-17-003316
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Flynn
Officer — Sr VP & Chief Commercial Offic
Period of report
Oct 20, 2017
Accepted (ET)
Oct 24, 2017 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 20, 2017 | A | 8 | $93.84 | A | 1,275 | I | Non-Qualified Deferred Compensation Plan |
| Common Stock | holding | — | — | — | 17,716 | D | ||
| Common Stock | holding | — | — | — | 252 | I | By Savings Plan |
Table II — derivative securities
No Table II lines on this filing.